Platelet-Activating Factor and Related Lipid Mediators

  • Fred Snyder

Table of contents

  1. Front Matter
    Pages i-xxi
  2. Introduction Historical Aspects of Alkyl Lipids and Their Biologically Active Forms (Ether Lipids, Platelet-Activating Factor, and Antihypertensive Renal Lipids)

  3. Methodology and Chemistry

    1. Front Matter
      Pages 7-7
    2. Robert C. Murphy, Keith L. Clay
      Pages 9-31
    3. Merle L. Blank, Mitchell Robinson, Fred Snyder
      Pages 33-52
  4. Composition

    1. Front Matter
      Pages 53-53
  5. Enzymes

  6. Antagonists, Agonists, and Receptors

  7. Biochemical and Biological Aspects in Specific Cells and Tissues

    1. Front Matter
      Pages 237-237
    2. Giovanni Camussi, Jan R. Brentjens
      Pages 299-322
    3. Stephen M. Prescott, Guy A. Zimmerman, Thomas M. McIntyre
      Pages 323-340
    4. B. Boris Vargaftig
      Pages 341-353
    5. Mariano Sanchez-Crespo, Pedro Iñarrea, Julian Gomez-Cambronero
      Pages 355-373
    6. Giora Feuerstein, Robert E. Goldstein
      Pages 403-424
    7. Jean Michel Mencia-Huerta, Ewa Ninio
      Pages 425-445
  8. Antitumor Analogs of PAF

    1. Front Matter
      Pages 447-447
    2. Wolfgang E. Berdel, Paul G. Munder
      Pages 449-467
  9. Back Matter
    Pages 469-471

About this book


Platelet-activating factor (PAF) is the commonly used name for a group of potent biologically active, ether-linked phospholipids, the alkylacetylglycerophospho­ cholines. Following the identification of the chemical structure of P AF in 1979, much progress has been made in our understanding of these phospholipid medi­ ators. This is particularly true from the points of view of their molecular structural requirements for expression of biological activity, their biosynthesis and cata­ bolism, their diverse range of biological activities, evidence for their specific recep­ tors at the cell surface, the development of specific antagonists for use in receptor studies and for testing as potential anti-PAF drugs, and implications about their involvement in health and disease. Chapters in this book cover the current status of these general areas of PAF research. Although an enormous amount of information has been published about this interesting new type of phospholipid mediators, questions about their mechanism of action, regulatory controls, and the precise role and relative importance of P AF in specific diseases and physiological functions remain to be answered. Since the 1979 discovery, the PAF field has brought together scientists from a variety of different biomedical disciplines. The diversity of scientists now in PAF research is very apparent from the number of P AF publications appearing in a wide array of scientific journals, ranging from molecular biology to clinical medicine. Publications related to PAF continue to increase at an amazingly rapid rate, with the pace reminiscent of the period following the discovery of prostaglandins.


Lipid Mammalia development enzymes metabolism tissue

Editors and affiliations

  • Fred Snyder
    • 1
  1. 1.Medical and Health Sciences DivisionOak Ridge Associated UniversitiesOak RidgeUSA

Bibliographic information

Industry Sectors
Chemical Manufacturing
Health & Hospitals
Consumer Packaged Goods